Post-PCI Anticoagulation with Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial

H Watanabe, M Natsuaki, T Morimoto… - The American Journal of …, 2024 - Elsevier
The current guidelines for acute coronary syndrome (ACS) have discouraged the use of
anticoagulation after percutaneous coronary intervention (PCI) without specific indications …

急性冠状动脉综合征围术期抗凝治疗的循证之路

聂绍平, 严研 - 临床心血管病杂志, 2024 - whuhzzs.com
抗栓治疗是急性冠状动脉综合征药物治疗的基石, 围术期抗凝治疗对于预防血栓形成和降低缺血
事件风险至关重要. 自二十世纪九十年代以来, 国际上围绕急性冠状动脉综合征患者冠状动脉 …

转运前抗凝对行直接PCI 的STEMI 患者冠脉血流及心功能的影响

李亚, 宋大庆, 孙树印, 王健, 王杰, 吴冬, 万冬梅 - 临床急诊杂志, 2024 - lcjz.whuhzzs.com
目的探讨急性ST 段抬高型心肌梗死(ST-segment elevation myocardial infarction, STEMI)
患者在转运至行经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI) …

The evidence-based path of perioperative anticoagulation therapy for acute coronary syndrome

NIE Shaoping, YAN Yan - J Clin Cardiol, 2024 - en.whuhzzs.com
Antithrombotic therapy is the cornerstone of drug treatment for acute coronary syndrome,
and perioperative anticoagulant therapy is crucial for preventing thrombosis and reducing …

Effects of pre-transport anticoagulation on coronary blood and cardiac function in patients with STEMI undergoing direct PCI

LI Ya, S Daqing, SUN Shuyin, W Jian, W Jie… - J Clin …, 2024 - lcjzen.whuhzzs.com
To investigate the effect of unfractionated heparin pretreatment on coronary blood flow,
cardiac function and in-hospital bleeding events in patients with acute ST-segment elevation …